Insider · CIK 0001697616
Erick Lucera
directorcfoofficer
Files at XAIR (Beyond Air, Inc.), EDIT (Editas Medicine, Inc.), DYN (Dyne Therapeutics, Inc.), SABS (SAB Biotherapeutics, Inc.). First filing Mar 5, 2025, latest Mar 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $7,030 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EDIT: Editas Medicine, Inc.
EDITOct 9, 2026 · close 2.90
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Editas Medicine, Inc. | $7,030 4,109 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | DYN Dyne Therapeutics, Inc. | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 131,100 | Feb 17, 2026 |
| Feb 12, 2026 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Feb 17, 2026 |
| Dec 16, 2025 | SABS SAB Biotherapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +150,000 | $0.00 | $0 | 150,000 | Dec 18, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -2,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +2,250 | - | - | 2,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -2,000 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +2,000 | - | - | 2,000 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,500 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,500 | - | - | 1,500 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,000 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,000 | - | - | 1,000 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -3,750 | - | - | 0 | Nov 6, 2025 |
| Nov 4, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +3,750 | - | - | 3,750 | Nov 6, 2025 |
| Mar 31, 2025 | DYN Dyne Therapeutics, Inc. | AGrant or award Common Stock | +66,100 | $0.00 | $0 | 66,100 | Apr 1, 2025 |
| Mar 31, 2025 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +214,500 | $0.00 | $0 | 214,500 | Apr 1, 2025 |
| Mar 26, 2025 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Mar 28, 2025 |
| Mar 8, 2025 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +275,100 | $0.00 | $0 | 275,100 | Mar 27, 2025 |
| Mar 8, 2025 | EDIT Editas Medicine, Inc. | AGrant or award Stock Option (right to buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Mar 27, 2025 |
| Mar 4, 2025 | EDIT Editas Medicine, Inc. | SOpen-market sale Common Stock10b5-1 | -4,109 | $1.71 | $7,030 | 112,720 | Mar 5, 2025 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -45,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +45,000 | - | - | 45,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -40,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +40,000 | - | - | 40,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -30,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +30,000 | - | - | 30,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -25,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +25,000 | - | - | 25,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -25,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +25,000 | - | - | 25,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -20,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +20,000 | - | - | 20,000 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | DDisposition to issuer Stock Options (Right to buy)derivative | -25,000 | - | - | 0 | Nov 26, 2024 |
| Nov 22, 2024 | XAIR Beyond Air, Inc. | AGrant or award Stock Options (Right to buy)derivative | +25,000 | - | - | 25,000 | Nov 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.